Michael H. Baumann

Zitiert von

	Alle	Seit 2020
Zitate	17559	5198
h-index	71	35
i10-index	234	141

1300

650

325

975

199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025123 106 126 108 198 180 276 257 238 340 457 479 581 570 545 552 592 748 781 780 931 1013 1032 1084 898 1215 912 1064 1014 89

Öffentlicher Zugriff

Alle anzeigen

147 Artikel

10 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Richard B RothmanIRP, NIDA, NIHBestätigte E-Mail-Adresse bei intra.nida.nih.gov
Charles W SchindlerNIH National Institute on Drug AbuseBestätigte E-Mail-Adresse bei helix.nih.gov
Harald H. SitteProfessor of Psychopharmacology, Medical University ViennaBestätigte E-Mail-Adresse bei meduniwien.ac.at
BL RothDepartment of Pharmacology, University of North Carolina Medical SchoolBestätigte E-Mail-Adresse bei med.unc.edu
Carl R. LupicaSenior Investigator, NIHBestätigte E-Mail-Adresse bei mail.nih.gov
Yavin ShahamIRP-NIDABestätigte E-Mail-Adresse bei intra.nida.nih.gov
Alexander F. Hoffman, Ph.D.National Institutes of Health, National Institute on Drug Abuse Intramural Research ProgramBestätigte E-Mail-Adresse bei intra.nida.nih.gov
Farhana SaklothDepartment of Neuroscience.Icahn School of Medicine at Mount SinaiBestätigte E-Mail-Adresse bei mssm.edu
Marta ConcheiroJohn Jay College, City University of New YorkBestätigte E-Mail-Adresse bei jjay.cuny.edu
Jean Lud Cadet, M.D.Molecular Neuropsychiatry Research BranchBestätigte E-Mail-Adresse bei intra.nida.nih.gov
Tom PrisinzanoUniversity of KentuckyBestätigte E-Mail-Adresse bei uky.edu
Matthew L BanksVirginia Commonwealth UniversityBestätigte E-Mail-Adresse bei vcu.edu
Gerhard F EckerProfessor of Pharmacoinformatics, University of ViennaBestätigte E-Mail-Adresse bei univie.ac.at
Gavin McLaughlin, PhDAthlone Institute of Technology; Trinity College DublinBestätigte E-Mail-Adresse bei research.ait.ie
Newman Amy HauckNational Institue on Drug Abuse-Intramural Research Program, NIHBestätigte E-Mail-Adresse bei intra.nida.nih.gov
Felix P MayerUniversity of CopenhagenBestätigte E-Mail-Adresse bei sund.ku.dk
Eugene A. Kiyatkin, MD, PhDIn-Vivo Electrorophysiology Unit, Behavioral Neuroscience Branch, NIDA-IRP, NIHBestätigte E-Mail-Adresse bei intra.nida.nih.gov
Ken T. WakabayashiAssistant Professor, Department of Psychology, University of Nebraska-LincolnBestätigte E-Mail-Adresse bei unl.edu
William A. Carlezon Jr. Harvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Carlo CifaniUniversity of Camerino, School of Pharmacy, ItalyBestätigte E-Mail-Adresse bei unicam.it

Folgen

Michael H. Baumann

Intramural Research Program, National Institute on Drug Abuse

Bestätigte E-Mail-Adresse bei mail.nih.gov


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin RB Rothman, MH Baumann, CM Dersch, DV Romero, KC Rice, FI Carroll, ... Synapse 39 (1), 32-41, 2001	1149	2001
Evidence for Possible Involvement of 5-HT_2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications RB Rothman, MH Baumann, JE Savage, L Rauser, A McBride, ... Circulation 102 (23), 2836-2841, 2000	853	2000
Monoamine transporters and psychostimulant drugs RB Rothman, MH Baumann European journal of pharmacology 479 (1-3), 23-40, 2003	629	2003
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue MH Baumann, MA Ayestas, JS Partilla, JR Sink, AT Shulgin, PF Daley, ... Neuropsychopharmacology 37 (5), 1192-1203, 2012	525	2012
Powerful cocaine-like actions of 3, 4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products MH Baumann, JS Partilla, KR Lehner, EB Thorndike, AF Hoffman, M Holy, ... Neuropsychopharmacology 38 (4), 552-562, 2013	496	2013
Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats WA Carlezon Jr, C Béguin, JA DiNieri, MH Baumann, MR Richards, ... The Journal of pharmacology and experimental therapeutics 316 (1), 440-447, 2006	481	2006
3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings MH Baumann, X Wang, RB Rothman Psychopharmacology 189, 407-424, 2007	310	2007
Misuse of novel synthetic opioids: a deadly new trend MP Prekupec, PA Mansky, MH Baumann Journal of addiction medicine 11 (4), 256-265, 2017	289	2017
N-substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’) MH Baumann, RD Clark, AG Budzynski, JS Partilla, BE Blough, ... Neuropsychopharmacology 30 (3), 550-560, 2005	261	2005
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension RB Rothman, MA Ayestas, CM Dersch, MH Baumann Circulation 100 (8), 869-875, 1999	260	1999
Psychoactive “bath salts”: not so soothing MH Baumann, JS Partilla, KR Lehner European journal of pharmacology 698 (1-3), 1-5, 2013	235	2013
Nitric oxide inhibits [3H] dopamine uptake S Pogun, MH Baumann, MJ Kuhar Brain research 641 (1), 83-91, 1994	233	1994
Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3, 4-methylenedioxypyrovalerone (MDPV) JA Marusich, KR Antonazzo, JL Wiley, BE Blough, JS Partilla, ... Neuropharmacology 87, 206-213, 2014	230	2014
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs S Wee, KG Anderson, MH Baumann, RB Rothman, BE Blough, ... Journal of Pharmacology and Experimental Therapeutics 313 (2), 848-854, 2005	220	2005
Therapeutic and adverse actions of serotonin transporter substrates RB Rothman, MH Baumann Pharmacology & therapeutics 95 (1), 73-88, 2002	216	2002
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil D Zolkowska, R Jain, RB Rothman, JS Partilla, BL Roth, V Setola, ... Journal of Pharmacology and Experimental Therapeutics 329 (2), 738-746, 2009	213	2009
Interaction of amphetamines and related compounds at the vesicular monoamine transporter JS Partilla, AG Dempsey, AS Nagpal, BE Blough, MH Baumann, ... Journal of Pharmacology and Experimental Therapeutics 319 (1), 237-246, 2006	191	2006
Serotonergic drugs and valvular heart disease RB Rothman, MH Baumann Expert opinion on drug safety 8 (3), 317-329, 2009	159	2009
Serotonin releasing agents: neurochemical, therapeutic and adverse effects RB Rothman, MH Baumann Pharmacology Biochemistry and Behavior 71 (4), 825-836, 2002	154	2002
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin DC Mash, JK Staley, MH Baumann, RB Rothman, WL Hearn Life sciences 57 (3), PL45-PL50, 1995	154	1995

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren